ArticleMolecular biotechnology2021

MiR-124-3p Suppresses Prostatic Carcinoma by Targeting PTGS2 Through the AKT/NF-κB Pathway.

Zhilei ZhangPubMed ↗Publisher ↗

No numbers read from the abstract.